Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Alzheimer Disease × selinexor × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 4 Recurrence 3 Solid Tumor Malignancy 1 Sarcoma, Ewing 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Rhabdoid Tumor 1 Recurrent Squamous Cell Lung Carcinoma 1 Neurofibrosarcoma 1 Neoplasm, Residual 1 Lymphoma, Large B-Cell, Diffuse 1 Liposarcoma 1 Immunoglobulin Light-chain Amyloidosis 1 Central Nervous System Neoplasms 1 Amyloidosis 1 Alzheimer Disease 1

Interventions

selinexor 1 XENP 1595 1 Tablets 1 Electroencephalography 1 Donepezil 1 Dexamethasone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04984330 2022-11-17

STARR

Weill Medical College of Cornell University

Phase EARLY_PHASE1 Withdrawn

Immunoglobulin Light-chain Amyloidosis, Alzheimer Disease, Amyloidosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡